The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use. 

"As cannabis legalization increases, it is crucial to understand the public health and clinical implications of marijuana use," researchers wrote in JAMA Cardiology.

The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.”

Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.

California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.

Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.

The dual-layer micromesh stent was designed with the flexibility of an open-cell stent and is available in multiple sizes.